These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28776437)

  • 41. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
    Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
    Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative evaluation of warfarin utilisation in two primary healthcare clinics in the Cape Town area.
    Njovane XW; Fasinu PS; Rosenkranz B
    Cardiovasc J Afr; 2013 Mar; 24(2):19-23. PubMed ID: 23750346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential interaction between azithromycin and warfarin.
    Foster DR; Milan NL
    Pharmacotherapy; 1999 Jul; 19(7):902-8. PubMed ID: 10417043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review of potential drug interaction between Oseltamivir and Warfarin and why it is important for emergency medicine physicians.
    Shah SP; Patel KM; Subedi R; Gambhir HS
    Am J Emerg Med; 2017 Aug; 35(8):1207.e3-1207.e4. PubMed ID: 28438444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Warfarin: implementing its safe use in hospitalized patients from nursing homes and community through a performance improvement initiative.
    Dharmarajan TS; Gupta A; Baig MA; Norkus EP
    J Am Med Dir Assoc; 2011 Sep; 12(7):518-23. PubMed ID: 21450178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonadherence with INR monitoring and anticoagulant complications.
    Witt DM; Delate T; Clark NP; Garcia DA; Hylek EM; Ageno W; Dentali F; Crowther MA
    Thromb Res; 2013 Aug; 132(2):e124-30. PubMed ID: 23800635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review.
    Verhovsek M; Motlagh B; Crowther MA; Kennedy C; Dolovich L; Campbell G; Wang L; Papaioannou A
    BMC Geriatr; 2008 Jul; 8():13. PubMed ID: 18598364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperprothrombinemia as a result of a possible warfarin and intravaginal miconazole interaction.
    Thomas JL; Dunn D; Pelletier A; Franks AS
    South Med J; 2010 Oct; 103(10):1063-5. PubMed ID: 20802381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of elderly adults taking warfarin admitted with prolonged international normalized ratio: a community hospital's experience.
    Bergman M; Ori Y; Blumberger N; Brener ZZ; Salman H
    J Am Geriatr Soc; 2012 Sep; 60(9):1713-7. PubMed ID: 22880717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system.
    Papaioannou A; Kennedy CC; Campbell G; Stroud JB; Wang L; Dolovich L; Crowther MA;
    BMC Geriatr; 2010 Jun; 10():38. PubMed ID: 20537178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance improvement in managed long-term care: improving warfarin medication management.
    Desmond D; Kogan P; Underwood S; Brobbey E; Luib P
    Home Healthc Nurse; 2009 Mar; 27(3):150-9. PubMed ID: 19279480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy.
    Hughes GJ; Patel PN; Saxena N
    Pharmacotherapy; 2011 Jun; 31(6):591-7. PubMed ID: 21923443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy.
    Oberg KC
    Pharmacotherapy; 1998; 18(2):386-91. PubMed ID: 9545160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
    Baker WL; Cios DA; Sander SD; Coleman CI
    J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
    Sandén P; Renlund H; Svensson PJ; Själander A
    Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of stress on international normalized ratio during warfarin therapy.
    Hawk TL; Havrda DE
    Ann Pharmacother; 2002 Apr; 36(4):617-20. PubMed ID: 11918508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the utility of an online registry for patients monitoring their own warfarin therapy.
    McCahon D; Baker JM; Murray ET; Fitzmaurice DA
    J Clin Pathol; 2016 Apr; 69(4):331-6. PubMed ID: 26519487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.